1. Fulcrum Therapeutics Inc
  2. Fulcrum Therapeutics Inc Ownership

Historical shareholding details of Bridgeway Capital Management, LLC holdings in Fulcrum Therapeutics Inc (FULC)

Monthly changes of Bridgeway Capital Management, LLC shareholding in Fulcrum Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Bridgeway Capital Management, Llc 140,000 0.26%
Jan 31, 2025 Bridgeway Capital Management, Llc 140,000 0.26%
Dec 31, 2024 Bridgeway Capital Management, Llc 140,000 0.26%
Dec 31, 2024 Bridgeway Capital Management, Llc 0 0.00%
Nov 30, 2024 Bridgeway Capital Management, Llc 0 0.00%
Oct 31, 2024 Bridgeway Capital Management, Llc 0 0.00%
Sep 30, 2024 Bridgeway Capital Management, Llc 0 0.00%
Aug 31, 2024 Bridgeway Capital Management, Llc 0 0.00%
Jul 31, 2024 Bridgeway Capital Management, Llc 0 0.00%
Jun 30, 2024 Bridgeway Capital Management, Llc 0 0.00%
Jun 30, 2024 Bridgeway Capital Management, Llc 88,564 0.14%
May 31, 2024 Bridgeway Capital Management, Llc 88,564 0.14%
Apr 30, 2024 Bridgeway Capital Management, Llc 126,500 0.20%
Mar 31, 2024 Bridgeway Capital Management, Llc 88,564 0.14%
Mar 31, 2024 Bridgeway Capital Management, Llc 126,500 0.20%
Feb 29, 2024 Bridgeway Capital Management, Llc 126,500 0.20%
Jan 31, 2024 Bridgeway Capital Management, Llc 126,500 0.20%
Dec 31, 2023 Bridgeway Capital Management, Llc 126,500 0.20%
Dec 31, 2023 Bridgeway Capital Management, Llc 126,500 0.20%
Nov 30, 2023 Bridgeway Capital Management, Llc 126,500 0.20%
Oct 31, 2023 Bridgeway Capital Management, Llc 126,500 0.20%
Sep 30, 2023 Bridgeway Capital Management, Llc 126,500 0.20%
Sep 30, 2023 Bridgeway Capital Management, Llc 126,500 0.20%
Aug 31, 2023 Bridgeway Capital Management, Llc 126,500 0.20%
Jul 31, 2023 Bridgeway Capital Management, Llc 0 0.00%
Jun 30, 2023 Bridgeway Capital Management, Llc 126,500 0.20%
Jun 30, 2023 Bridgeway Capital Management, Llc 0 0.00%
May 31, 2023 Bridgeway Capital Management, Llc 0 0.00%
Mar 31, 2023 Bridgeway Capital Management, Llc 0 0.00%

View all ownership details of Fulcrum Therapeutics Inc